The Comprehensive Strategic Blueprint

An interactive deep-dive into the PRANA MSR Health operational strategy. Explore our initial investments, technology infrastructure, rigorous compliance roadmap, multi-channel marketing, and robust 5-year financial projections.

1. Capital Foundation

Initial Investment & Deployment

A structured approach to capital allocation, beginning with our immediate China R&D prototyping budget and scaling into a 5-year pan-India deployment strategy.

Initial R&D and Capital Deployment Breakdown

Phase 0: Immediate R&D Budget

We are executing a highly optimized immediate prototyping phase to validate hardware and local software integration during the 30–40 day Shenzhen sourcing sabbatical.

Seed Round: ₹16.00 Cr

Y1 CapEx: ₹4.30 Cr

Y1 Team: 39 FTEs

5-Year Capital & Deployment

Total equity funding of ₹111 Cr across three rounds to reach Pan-India scale — 400 kiosks, 85 pods, 22 mobile units, and 290 FTEs.

Total Funding: ₹111 Cr (Seed + A + B)

5-Yr CapEx: ₹8.00 Cr

Y5 Revenue: ₹319.04 Cr

2. Technology Stack

The 10-Platform Ecosystem

PRANA is not just hardware. It is a massive, interconnected digital health ecosystem orbiting a central Medical AI core, integrated with Google Cloud Platform and ABDM frameworks.

Platform	Core Functionality & Tech	Revenue Model
1. MSR Connect™	Telemedicine network with integrated EMR. Connects rural kiosks directly to specialist doctors via HD video.	Consult fees (25–35% share), Doctor SaaS (₹3K–8K/mo)
2. GlobeBlood	Real-time IoT-enabled blood bank inventory tracker.	Hospital partnership fees, Govt contracts
3. GlobeOrgan	Organ donation registry with AI matching engine.	Institutional subscriptions
4. GeoHealth Karnataka	Macro-level disease mapping & outbreak detection using anonymized screening data.	Govt health dept analytics (₹25–100L/yr)
5. PranaDrug	Drug interaction checker using FDA databases.	Pharmacy integration commission (3–8%)
6. PRANA Dental™	AI-powered intraoral 3D scanner workflow.	Device sales, facilitation fees
7. Prana Talk™	Ambient medical voice AI recorder. Converts doctor-patient speech into structured SOAP notes.	Hardware sales (₹28K), SaaS (₹3K/mo)
8. AI Decision Support	Core clinical workflow support (CDSS). Uses Vertex AI.	Platform licensing, Screening fees
9. MSR Pulse	Population health monitoring dashboard for admins.	Insurance analytics contracts
10. PRANA Mobile App	Citizen health records (ABHA linked) + AI Chatbot.	Consumer engagement, cross-selling

3. Regulatory Moat

Rigorous Compliance & Clinical Validation

Operating at the intersection of AI and Healthcare requires the highest levels of global regulatory compliance, data privacy, and ethical governance.

Data Privacy & Security

🛡️ DPDP Act 2023: Full compliance with India's new Digital Personal Data Protection Act. Explicit regional-language consent required.
🔐 Encryption: AES-256 encryption for all data at rest and in transit on Google Cloud infrastructure.
🏥 ABDM Integration: Native Ayushman Bharat Health Account (ABHA) creation and linkage.
⚠️ Medico-Legal Disclaimer: The AI acts strictly as a Clinical Decision Support System (CDSS) for triage, NEVER as an autonomous diagnostician.

Phase	Certifications Roadmap	Timeline
Phase 1	ISO 13485 (QMS), SUGAM registration, Import License (MD-14).	Months 1-6
Phase 2	CDSCO Product Registration, BIS, WPC, ABDM M3 Certification.	Months 6-12
Phase 3	Mfg License (MD-10) for local assembly, ISO 27001, AI Sensitivity trials.	Months 12-18
Phase 4	Software as a Medical Device (SaMD) Validation, CE Marking.	Years 2-3

4. Product Superiority

Core Advantages & Risk Mitigation

Combining 60+ diagnostic parameters with edge computing to deliver unprecedented clinical depth in a 6-minute automated workflow.

Why Prana Wins

Most kiosks measure 15-20 basic vitals. PRANA MSR Health captures 60+ parameters including 12-lead ECG, comprehensive lipid profiles, HbA1c, and advanced respiratory metrics—equivalent to a Tier-1 hospital baseline diagnostic.

This density of data allows our Medical LLMs to perform high-precision predictive risk stratification that simple rule-based software cannot match.

Key Risk Mitigation Strategies
Identified Risk	Impact	PRANA Mitigation Strategy
Hardware Supply Chain Shock	High	Dual-source strategy. Structured Make-in-India roadmap to transition 60% of manufacturing to domestic EMS partners by Year 2.
AI Hallucination / Liability	Critical	Continuous "Human-in-the-Loop" validation. AI output is explicitly watermarked as triage/decision-support only.
Govt Procurement Delays	Medium	Multi-channel approach. We do not rely solely on B2G. Strong B2B and franchise pipeline mitigates cash-flow stalls.

5. Go-To-Market

Marketing Strategy & Scaling

A multi-channel distribution strategy designed to capture B2B hospital networks, secure large B2G government contracts, and empower local franchises.

Phased District Scaling

We are executing a structured, geographical rollout starting from our Bengaluru headquarters.

📍 Phase 1 (Year 1): 5 Districts — 25 Kiosks + 5 Pods + 2 Mobile Units. 39 FTEs.
📍 Phase 2 (Year 2–3): All 31 Karnataka Districts — 150 Kiosks + 30 Pods + 10 Mobiles. 143 FTEs.
📍 Phase 3 (Year 4–5): South India & National expansion — 400 Kiosks + 85 Pods + 22 Mobiles. 290 FTEs.

Hospital & Doctor Tiering

Creating an incentivized referral network ensures that kiosks drive actual admissions and teleconsultations.

⚕️ Platinum Hospitals: Multi-specialty (500+ beds). High admission facilitation fee (₹1,500).
👨‍⚕️ Tier 1 Doctors: Senior specialists dedicating 2+ hours daily. 75/25 revenue split.
📈 Target: 2,800 active network clinicians by Year 5.

6. Revenue Architecture

Business Model & Costing Projections

Balancing capital-intensive hardware sales with high-margin recurring software operations.

Module A: Hardware Unit Costing
Product	Blended COGS	Selling Price (Gross Margin)
AI Kiosk (MSR-H650)	₹13.0L	₹18.5L (29.7%)
Pod Clinic (500 sqft)	₹13.0L	₹25.0L (48.0%)
Mobile Van (Force)	₹75.0L	₹85.0L (41.0%)
Prana Talk Device	₹12,500	₹28,000 (55.0%)

Per-Kiosk Unit Economics (Module B)

The operational margins of a single own-deployed kiosk under mature (Y5) utilization:

💰 Fee / Encounter: ₹250 (Y5) — scales from ₹150 in Y1
📈 Encounters / Unit / Month: 700 (Y5 mature)
👥 Y5 Total Encounters: 27.72 Lakh (across 330 avg active)
💵 Kiosk Revenue (Y5): ₹69.30 Cr
⏱️ CAC Payback: ~1.7 Months (Y5 logo-level)

Module B: Revenue Per Walk-In Patient

7. Capitalization Strategy

Funding Structure & Use of Funds

A phased equity financing structure of ₹111 Cr across Seed, Series A, and Series B — designed to fund deployment ramp, working capital, and software ecosystem scaling while maintaining a strong balance sheet.

Funding Stages & Deployment
Round	Target Amount	Primary Use of Funds
Seed	₹16 Cr	Prototyping, CDSCO/ISO compliance, initial 25 kiosks + 5 pods + 2 mobile units pilot in Karnataka. Pre-money ₹48 Cr / Post-money ₹64 Cr.
Series A	₹55 Cr	Full Karnataka rollout (150 kiosks), working capital expansion, software ecosystem scaling. Pre-money ₹165 Cr / Post-money ₹220 Cr.
Series B	₹40 Cr	South India & national scaling (260→400 kiosks), assembly facility. Pre-money ₹360 Cr / Post-money ₹400 Cr.
Post-Series B	Strategic PPP	Pan-India public sector fleet expansion and Arogya Karnataka integration. Y5 exit valuation: ₹2,074 Cr (6.5x base).

Projected Shareholding & Dilution Model (Post All Rounds)
Stakeholder Category	Post-Seed	Post-Series A	Post-Series B (Y5)
Founders & MSR Group	75.0%	56.25%	50.625%
Seed Investors	25.0%	18.75%	16.875%
Series A Investor	—	25.0%	22.5%
Series B / Institutional PE	—	—	10.0%
CHECK: Total	100%	100%	100%

8. Competitive Landscape

Market Comparison

How PRANA MSR Health differentiates itself from pure-play software aggregators and basic hardware vendors.

Competitor Profile	Ecosystem Strength	Telemedicine	ABDM Ready	The PRANA Difference
PRANA MSR Health	Hardware + AI + Ramaiah Hospital Network	Native Workflow	Native	60+ Parameters + Deep AI Clinical Support
Basic Health ATMs (e.g. YoloHealth)	Kiosk Hardware only	Basic	Planned	Lacks deep clinical workflow and brand trust.
Remote Monitoring (e.g. Dozee)	Strong Continuous Vitals	No	Yes	Focused on ICU beds, not walk-in preventive screening.
Aggregators (e.g. Tata 1mg, Apollo 24/7)	Strong Consumer Analytics & App base	App-based	Partial/Yes	Lacks physical hardware diagnostic infrastructure in rural areas.

9. Proforma P&L

5-Year Profit & Loss Statement (₹ Lakhs)

Formula-driven from Investor Model v5. Revenue recognition per Ind AS 115. All cells reference the Assumptions sheet — zero manual override.

Line Item	FY26-27	FY27-28	FY28-29	FY29-30	FY30-31
Revenue	260	1,911	6,546	15,954	31,904
Total COGS	247	1,251	3,147	6,444	12,546
Gross Profit	14	661	3,399	9,510	19,358
Gross Margin %	5.3%	34.6%	51.9%	59.6%	60.7%
S&M (comp + programs)	130	765	2,487	5,584	10,209
R&D (comp + cloud)	470	1,010	928	1,066	1,285
G&A (comp + rent + other)	131	421	1,178	2,393	4,148
Total OpEx	731	2,195	4,593	9,043	15,642
EBITDA	(717)	(1,534)	(1,194)	467	3,716
EBITDA Margin %	-275.5%	-80.3%	-18.2%	2.9%	11.6%
Depreciation	86	110	120	136	160
Interest Income	0	22	207	130	309
Tax (25.17%)	0	0	0	116	973
Net Income	(803)	(1,622)	(1,107)	346	2,893

The MedTech J-Curve: Deconstructing PRANA Health's 5-Year Proforma

A detailed walkthrough of our financial model, capital deployment strategy, and the trajectory from R&D investment to exponential SaaS revenue.

10. Revenue Architecture

Bottom-Up Revenue Model by Product Line

Six distinct revenue streams driving ₹319 Cr Y5 topline. Platform SaaS overtakes hardware by Year 3 — reaching 60% of revenue mix by Year 5.

Revenue Stream	FY26-27	FY27-28	FY28-29	FY29-30	FY30-31
Kiosk Encounters	₹56L	₹312L	₹1,260L	₹3,321L	₹6,930L
Pod Subscriptions	₹36L	₹180L	₹486L	₹1,020L	₹1,848L
Mobile Unit Contracts	₹120L	₹473L	₹1,125L	₹2,080L	₹3,230L
MSR Services (Assembly+AMC)	₹48L	₹98L	₹245L	₹435L	₹696L
Platform SaaS (Clinicians)	₹0	₹825L	₹3,250L	₹8,450L	₹18,000L
PranaDrug (Rx)	₹0	₹24L	₹180L	₹648L	₹1,200L
TOTAL REVENUE	₹2.60 Cr	₹19.11 Cr	₹65.46 Cr	₹159.54 Cr	₹319.04 Cr
Hardware/Services Mix	100%	55.6%	47.6%	43.0%	39.8%
Platform/SaaS Mix	0%	44.4%	52.4%	57.0%	60.2%

Deployment Fleet (EOP)

🏥 AI Kiosks: 25 → 60 → 150 → 260 → 400
🏢 Pod Clinics: 5 → 15 → 30 → 55 → 85
🚐 Mobile Units: 2 → 5 → 10 → 16 → 22
👨‍⚕️ Clinicians: 150 → 400 → 900 → 1,700 → 2,800
👥 FTEs: 39 → 86 → 143 → 209 → 290

Valuation Bridge (Y5 Exit)

📊 Y5 Revenue: ₹319 Cr
🐻 Bear (5.0x): ₹1,595 Cr EV
📈 Base (6.5x): ₹2,074 Cr EV
🐂 Bull (8.0x): ₹2,552 Cr EV
💎 Seed MOIC: 21.9x | Series A: 8.5x | Series B: 5.2x
🏆 Founder Equity Value: ₹1,050 Cr (at 6.5x base)

11. Growth Trajectory

Comprehensive Financial Projections

Interactive data visualizations from the formula-driven 5-Year Investor Model v5. All figures in ₹ Crores sourced directly from the P&L, Revenue Model, Balance Sheet, and Scenarios sheets.